203 results
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:08am
or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:03am
or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product
6-K
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:02am
; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
9 May 24
Current report (foreign)
6:01am
; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
19 Apr 24
Current report (foreign)
6:12am
(SC CD Trial), a Phase 3, randomized, double-blind, placebo-controlled trial, which assessed the safety and efficacy of an SC formulation of ENTYVIO … ) at Week 52.1 In clinical studies, the ENTYVIO SC safety profile was generally consistent with the known safety profile of ENTYVIO IV, with the addition
6-K
k4pog
15 Apr 24
Current report (foreign)
6:02am
6-K
c3s1on2umn8537pk66hm
9 Feb 24
Current report (foreign)
6:03am
6-K
wmkg2uwplroa4yst5 1f
2 Feb 24
Current report (foreign)
6:16am
6-K
kulub1rs aerg2s0lb4
1 Feb 24
Current report (foreign)
6:18am
6-K
EX-99.1
tqxk90
1 Feb 24
Current report (foreign)
6:06am
6-K
ky1refoa
16 Jan 24
Current report (foreign)
6:01am
6-K
EX-99.1
qn92t xay
14 Dec 23
Current report (foreign)
6:01am
6-K
EX-99.1
6yj8s6ao39
30 Nov 23
Current report (foreign)
6:01am
6-K
ggkrrp8y6c
13 Nov 23
Current report (foreign)
6:05am
6-K
kjzck3
30 Oct 23
Current report (foreign)
6:02am
6-K
EX-99.1
yvfwrhgjrmb
30 Oct 23
Current report (foreign)
6:02am
6-K
x7h264
26 Oct 23
Current report (foreign)
6:22am
6-K
EX-99.1
qhxk5n7
26 Oct 23
Current report (foreign)
6:20am
6-K
EX-99.1
mec6v7i4apwvk7u9hw9n
18 Oct 23
Current report (foreign)
6:21am
6-K
EX-99.1
38c5ubzln1arosxg8m6
18 Oct 23
Current report (foreign)
6:20am